About 22 million Americans would face sharply higher healthcare costs if enhanced ACA tax credits expire at the end of the ...
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...
The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...
Oral Genome, a leader in saliva-based oral health testing, has been honored with the 2025 Cellerant Best of Class Hygiene Award, recognizing the company’s innovative contribution to preventive oral ...
Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...
Provider organizations are continuing to adopt AI tools across their departments and clinics, and ambient documentation startups are facing the challenge of differentiating themselves in a field ...
The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...
Cigna Healthcare has teamed up with mental health company Headspace to offer digital support for its members, the companies announced on Monday. The partnership, called Headspace for Cigna Healthcare, ...
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program open to products addressing certain national health priorities. Rare and infectious ...
Pluto Health has launched a partnership with Help.AI that aims to support clinicians with surgical evaluations, the companies announced on Thursday. Durham, North Carolina-based Pluto Health is a spin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results